Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dolby Laboratories (DLB) Shares Outstanding (Diluted Average) (2016 - 2025)

Dolby Laboratories' Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $96.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 0.65% year-over-year to $96.5 million; the TTM value through Dec 2025 reached $96.5 million, down 0.65%, while the annual FY2025 figure was $97.5 million, 0.16% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $96.5 million in Q4 2025 per DLB's latest filing, down from $97.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $104.6 million in Q3 2021 to a low of $96.5 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $99.5 million, with a median of $97.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 1.65% in 2021, then dropped 6.51% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $103.8 million in 2021, then dropped by 6.51% to $97.0 million in 2022, then increased by 0.4% to $97.4 million in 2023, then dropped by 0.3% to $97.1 million in 2024, then dropped by 0.65% to $96.5 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Shares Outstanding (Diluted Average) are $96.5 million (Q4 2025), $97.5 million (Q3 2025), and $96.9 million (Q2 2025).